News & Updates

Faster ageing blamed for global surge in early-onset cancers

People born in 1965 or later show signs of accelerated ageing, a phenomenon that is potentially related to the rising incidence of early-onset solid tumours worldwide, according to a large study.

Does metoclopramide improve endoscopic visualization in patients with UGIB?

Use of metoclopramide proves inadequate in enhancing endoscopic visualization among patients with overall active upper gastrointestinal bleeding (UGIB), reports a study. However, it does reduce the need for second look esophagogastroduodenoscopy (EGD).

Can prophylactic biologic mesh in IC prevent parastomal hernia?

Use of biologic mesh at the time of ileal conduit (IC) construction is safe and feasible in patients undergoing cystectomy but falls short of providing protective effects against parastomal hernia (PSH) within 2 years following surgery, reports a study.

Low-carb diet eases pain, improves QoL in women with lipedema

Women with lipedema who lose weight through proper diet can see improvements in their quality of life (QoL), suggests a study. Specifically, an energy-restricted low-carbohydrate diet (LCD) appears to be better at pain reduction than a standard control diet.

CD38 monoclonal antibody shows promise in kidney transplant rejection

In the treatment of kidney transplant recipients with antibody-mediated rejection, the CD38 monoclonal antibody felzartamab demonstrates acceptable safety and side-effect profiles as well as potential therapeutic benefit, according to a phase II trial.

Novel protocol allows remote diagnosis of retinal artery occlusion

Remote consultation using point-of-care automated optical coherence tomography (OCT) is feasible in the diagnosis of retinal artery occlusion, suggests a study.

1-day on par with 5-day octreotide in preventing bleeding, death from esophageal varices

A 1-day regimen of octreotide infusion, along with endoscopic therapy for variceal bleeding, does not appear to be inferior to the standard 5-day regimen in the prevention of rebleeding and all-cause mortality at 6 weeks, according to the preliminary results of a study.